Holen Sie sich die Stockscreener-App
37.70
0.66%
-0.25
Handel nachbörslich:
37.70
Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten
Aug Ideas: Is Agios Pharmaceuticals Inc. stock a top performer YTDTrade Exit Report & Accurate Technical Buy Alerts - khodrobank.com
Is it too late to sell Agios Pharmaceuticals Inc.Share Buyback & Consistent Income Trade Recommendations - newser.com
Pattern recognition hints at Agios Pharmaceuticals Inc. upsideJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com
Trading Action: Is Agios Pharmaceuticals Inc a defensive stockMarket Trend Review & Verified Stock Trade Ideas - khodrobank.com
Rhumbline Advisers Reduces Stock Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Agios drops as FDA delays review of thalassemia drug - MSN
Support Test: Is Agios Pharmaceuticals Inc a defensive stockJuly 2025 Earnings & Accurate Buy Signal Alerts - خودرو بانک
What is the long term forecast for Apellis Pharmaceuticals Inc stock2025 Trading Recap & Fast Entry High Yield Tips - khodrobank.com
How to escape a deep drawdown in Agios Pharmaceuticals Inc.Risk Management & Long Hold Capital Preservation Tips - newser.com
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
Using Ichimoku Cloud for Agios Pharmaceuticals Inc. technicalsEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com
Quarterly Risk: Is COOTW stock heavily shortedMarket Risk Summary & Technical Buy Zone Confirmation - خودرو بانک
Tools to assess Agios Pharmaceuticals Inc.’s risk profileWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com
Agios Pharmaceuticals’ SWOT analysis: FDA delay impacts stock outlook By Investing.com - Investing.com Canada
Agios Pharmaceuticals’ SWOT analysis: FDA delay impacts stock outlook - Investing.com
Rhumbline Advisers Sells 7,666 Shares of Agios Pharmaceuticals, Inc. $AGIO - Defense World
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives $56.00 Average PT from Analysts - MarketBeat
Tools to monitor Agios Pharmaceuticals Inc. recovery probabilityJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Forecast Cut: What is Agios Pharmaceuticals Incs market position2025 Trading Volume Trends & Low Volatility Stock Recommendations - khodrobank.com
What momentum shifts mean for Agios Pharmaceuticals Inc.July 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com
Rate Hike: What are LSAKs recent SEC filings showingPortfolio Update Report & Community Driven Trade Alerts - خودرو بانک
Risk Analysis: Is Agios Pharmaceuticals Inc stock good for income investorsPortfolio Profit Report & AI Driven Stock Movement Reports - khodrobank.com
Day Trade: Will Agios Pharmaceuticals Inc outperform tech stocksDividend Hike & Community Verified Trade Signals - خودرو بانک
Aug Macro: Can IBIO stock double in the next yearJuly 2025 Levels & Reliable Intraday Trade Plans - خودرو بانک
Real time alert setup for Agios Pharmaceuticals Inc. performance2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Forecasting Agios Pharmaceuticals Inc. price range with options dataWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
What does recent volatility data suggest for Agios Pharmaceuticals Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm - Business Wire
Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer - GlobeNewswire Inc.
Surprises Report: Is Agios Pharmaceuticals Inc a good ESG investmentPortfolio Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Insider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 8,546 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - PR Newswire
SCS Capital Management LLC Purchases Shares of 611,098 Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
HC Wainwright Issues Pessimistic Estimate for AGIO Earnings - MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO - Louisiana First News
Agios Pharmaceuticals, Inc. $AGIO Shares Purchased by Granahan Investment Management LLC - MarketBeat
Agios Pharmaceuticals, Inc. $AGIO Shares Purchased by Boothbay Fund Management LLC - MarketBeat
Cutter Capital Management LP Trims Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Adage Capital Partners GP L.L.C. Boosts Stake in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Is Agios Pharmaceuticals Inc. stock technically oversold2025 Bull vs Bear & Real-Time Price Movement Reports - Lancaster City Council
What is the earnings history of Agios Pharmaceuticals Inc.Quarterly Trade Summary & AI Driven Price Predictions - Lancaster City Council
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - MarketScreener
Agios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A Positive (NASDAQ:AGIO) - Seeking Alpha
FDA Review Delay for PYRUKYND Might Change the Case for Investing in Agios Pharmaceuticals (AGIO) - Yahoo Finance
Palo Alto Investors LP Buys Shares of 276,578 Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Northern Trust Corp Has $16.88 Million Position in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):